Pharma/Biotech – USA, Europe, Asia and ROW Regulatory News – Sept 2024
USA
FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia
The U.S. Food and Drug Administration granted approval for Cobenfy (xanomeline and trospium chloride) capsules...
Asia Regulations, Drug Approvals, EMA, Europe Pharma, FDA, Global Health, Safety Updates, USA Drug Updates